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Safe Limits of Contrast Vary with Hydration Volume:Prevention of Contrast-
Induced Nephropathy after Coronary Angiography
Ji-yan Chen1, Yong Liu1
1Department of cardiology, Guangdong Cardiovascular Institute, Guangdong general
hospital, Guangzhou, Guangdong
Background: There have been few studies of the prevention of contrast-induced
nephropathy(CIN)on investigating the effect of intravenous hydration volume on
relative safe maximum volume of contrast.This study investigated the effect of
intravenous hydration volume on the safe maximum volume of contrast.
Methods: The ratios of contrast volume to creatinine clearance(V/CrCl)and hydration
volume to body weight(HV/W)were determined in patients undergoing coronary
angiography. Receiver-operator characteristic(ROC)curve analysis based on the
maximum Youden index was used to identify the optimal cutoff for V/CrCl in all
patients and in different hydration volume sub-groups(HV/W12and>12).
Results: Eighty-six of 3273(2.63%)patients developed CIN.ROC curve analysis
indicated that V/CrCl>2.44 was a predictor for CIN in all patients
(sensitivity¼71.6%, speciﬁcity¼70.5%,C-statistic:0.780), and V/CrCl>2.44 was
signiﬁcantly and independently related to the risk of CIN (adjusted OR:4.157;95%
CI:2.449-7.059,p < 0.0001)(age > 75, diabetes, congestive heart failure, emergent
coronary angiography, anemia, hypertension, intra-aortic balloon pump, hypoten-
sion) and the risk of 2 year death (adjusted HR:2.62;95%CI:1.84-3.87, p<
0.0001), even after including other clinical and procedural variables in multivariate
logistic regression,the V/CrCl ratio for CIN was1.87 in the insufﬁcient
hydration subgroup (HV/W12,sensitivity¼67.9%,speciﬁcity¼64.4%,C-statisti-
c:0.739,adjusted OR:3.239;95%CI:1.312-7.995,p¼0.0108)and2.93in the sufﬁcient
subgroup(HV/W>12,sensitivity¼69.0%,speciﬁcity¼65.0%,C-statistic:0.732,adjusted
OR:3.040;95%CI:1.640-5.633,p¼0.0004).
Conclusions: Individual relative safe maximum volume of contrast during coronary
angiography adjusted with different hydration volume may be more reliable even with
the signiﬁcance of long-term prognosis. We could moderately relax limits of contrast
dose among patients with adequate hydration.
Table1. Univariate Analysis and Multivariate Associations between CIN and
V/CrCl for patients HV/W>12Variable
Univariate Analysis Multivariate Analysis
OR CI p OR CI p
V/CrCl>2.93 4.133 2.338-
7.307
<0.0001 3.040 1.640-
5.633
0.0004
Age 75
years
2.514 1.467-
4.306
0.001 1.964 1.084-
3.559
0.0259
Hypotension 3.745 2.187-
6.411
<0.0001 2.295 1.255-
4.196
0.0070
IABP 1.041 0.576-
1.880
0.894
Emergent
PCI
1.409 0.790-
2.512
0.246
Hypertension 2.845 1.623-
4.984
<0.0001 2.214 1.190-
4.122
0.0122
Diabetes 8.527 4.471-
16.264
<0.0001 4.139 1.985-
8.629
0.0002
CHF 5.294 1.910-
14.673
0.001
Anemia 1.872 1.092-
3.210
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Background: Radiocontrast-induced acute kidney injury (RAKI), is associated with
increased short and long-term mortality, and poor renal outcomes. The usefulness of
sodium bicarbonate (SB) compared with normal saline (NS) in preventing RAKI in
patients undergoing coronary angiography with renal dysfunction is controversial. The
goal of the PRIMARY study was to evaluate the 1-year and 5-year, clinical and renal
outcomes of SB versus NS in preventing RAKI, in patients with chronic kidneyB76 JACC Vol 64/11/Suppl B j September 13–17disease (CKD) stage III-IV undergoing coronary diagnostic and interventional
procedures.
Methods: Three-hundred and ninety six patients (n¼396) (mean age: 6712) (52%
males) with a GFR < 60 mL/min/1.73m2, undergoing elective coronary angiography
were included in the study using an iso-osmolar contrast agent. Patients were ran-
domized to receive either 154 mEq/L of intravenous ( I.V.) SB (n ¼ 192) or NaCl (n ¼
190) with 5% dextrose at 3 mL/kg for one hour before contrast administration fol-
lowed by 1 mL/kg/hr for 6 hours post- procedure. Renal function was measured in all
patients before, and 48 hours after contrast administration. Incidence of RAKI, in-
hospital, 1 year and 5 year mortality and renal outcomes were compared between
groups. RAKI was deﬁned as increase in serum creatinine > 0.5 mg/dL or an increase
from > 25% baseline within 48 hours after the administration of contrast.
Results: There were no statistically signiﬁcant differences in each group regarding
baseline demographics, medical therapy, renal function or co-morbidities, contrast
volume used, hydration volume pre- and post-procedure, coronary artery severity,
incidence of revascularization and ejection fraction.
No signiﬁcant differences between groups were noted in the incidence of RAKI [25
(13%) treated with SB vs. 31 (16%) with NS (p¼ 0.89)]. The in-hospital mortality, 1
or 5-year mortality or need for renal replacement therapy was not statistically different
between groups.
Conclusions: In patients with stage III-IV CKD undergoing diagnostic and/or inter-
ventional coronary angiographic procedures, the use of SB is as effective as NS in
preventing RAKI, with similar in-hospital, 1 and 5 year mortality and need for renal
replacement therapy.
TCT-260
Abstract Withdrawn
TCT-261
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Background: Contrast-induced acute kidney injury (CI-AKI) is associated to increased
morbidity, mortality, health costs and prolonged hospitalization. Common deﬁnitions
of CI-AKI are: a relative increase in Serum Creatinine (SCr) of at least 25% from the
baseline values (deﬁnition 1), an absolute increase in SCr concentration of at least 0.5
mg/dL (deﬁnition 2), and an absolute increase in SCr of at least 0.3 mg/dL (deﬁnition 3),
all presenting within 48-72 hours. This study has two main aims: a) to prospectively
describe the long-term outcomes in a population at high-risk of CI-AKI development b)
to clarify which deﬁnition of CK-AKI correlates best with long-term events.
Methods: Monocentric, prospective, observational registry enrolling patients under-
going coronary angiography with at least one of: age 75; diabetes; stages 2 or 3
chronic kidney disease (NKF) or ST-segment elevation myocardial infarction
(STEMI). Biochemical determinations were assessed at baseline under preventive
hydration and 12, 24, 48 and 72 hours thereafter. Blood examinations were repeated
also at 1 month and subsequently every 6 months after discharge.Primary clinical end-
point was a composite of death, MI and need for dialisys.
Results: We enrolled 216 patients (72% males; mean age 70 years) followed for a
median of 1121 days. Thirthy-nine patients(18.1%) developed CI-AKI by deﬁnition 1,
16(7.4%) by deﬁnition 2 and 37(17.1%) by deﬁnition 3. 20% of patients had baseline
mild/moderate renal dysfunction (GFR>30 mL/min/1.73m2), while 46.7% were di-
abetics. At complete FU we observed 10 CV deaths(4.6%), 5 non-CV deaths(2.3%),
9(4.2%) MIs, 7(3.2%) major stokes and 6(2.8%) need for chronic dialysis. At Cox-
regression only CI-AKI assessed by deﬁniton 3 predicted primary EP(p¼0.04; HR:
2.168; 95%CI: 1.193-4.734). Renal impairment persisted at 30 days in 40.5% of CI-
AKI deﬁnition 3 patients and was associated with worst long-term outcome(p<
0.001;HR4.758.95%CI:2.039-11.100).
Conclusions: High-risk CI-AKI patients had 13.9% primary EP at 3-years.An abso-
lute increase in SCr of at least 0.3 mg/dL seems within 72h seems the most clinically
useful CI-AKI deﬁnition. Persistent renal damage at 30 days correlates with poorer
outcomes.
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Background: Everolimus-eluting stent (EES) is one of the most commonly used
newer generation drug-eluting stent (DES) in clinical practice. However, the relative
merits of EES against the previous gold-standard sirolimus-eluting stent (SES) for
patients with renal insufﬁciency (RI) have been less extensively assessed. We aimed to
evaluate the three-year outcomes after SES and EES implantation for patients with RI., 2014 j TCT Abstracts/Renal Insufﬁciency and Contrast Nephropathy
